Surrozen, Inc.
Surrozen, Inc. (SRZN) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · SRZN · as of Jun 9, 2026
Key Statistics
Explore Surrozen, Inc. Data
srzn stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 6 · Buy rate: 66.7%
The SRZN analyst consensus is Buy, based on ratings from 6 Wall Street analysts over the past 3 months. The average 12-month price target is $42.00, representing +103.00% upside from the current price of $20.69.
Competitors & Peers
srzn competitorsSRZN
AGEN
ATOS
CGTX
GLSI
IMMXStock Performance
Full HistoryAbout Surrozen, Inc.
Surrozen, Inc. is a biotechnology firm dedicated to discovering and advancing pharmaceutical agents that precisely modify the Wnt pathway to facilitate tissue healing and regeneration. The company eng…
what is surrozen, inc. · srzn stock overview · surrozen, inc. company profile · who is surrozen, inc. ceo · srzn NASDAQ · surrozen, inc. headquarters · surrozen, inc. business segments
About Stock Overview & Key Data
Surrozen, Inc. (SRZN) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jan 11, 2021. As of the latest trading session, SRZN stock price is $20.69, with a market capitalization of $154.7M. The stock has returned +135.11% over the past 12 months and -8.45% year-to-date.
According to 6 Wall Street analysts, the consensus rating for Surrozen, Inc. stock is Buy, with an average 12-month price target of $42.00. In fiscal year 2025, Surrozen, Inc. reported revenue of $3.5M and net income of -$242.0M. For detailed data — including Surrozen, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Surrozen, Inc. (SRZN) stock price is $20.69. The stock is traded on NASDAQ under the ticker symbol SRZN. The 52-week range is $8.00 – $35.00.